These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 25517440)

  • 21. Dose Optimization of Hybrid Imaging.
    Fahey FH
    Health Phys; 2019 Feb; 116(2):179-183. PubMed ID: 30585961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography-magnetic resonance imaging in the evaluation of brain tumors: current status and future prospects.
    Nguyen N; Montagnese J; Rogers LR; Sher A; Wolansky L
    Semin Roentgenol; 2014 Jul; 49(3):275-89. PubMed ID: 25497912
    [No Abstract]   [Full Text] [Related]  

  • 23. Nuclear investigative techniques and their interpretation in the heart and vascular disease.
    Ora M; Gambhir S
    Ann Card Anaesth; 2020; 23(3):262-271. PubMed ID: 32687080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid Imaging in Oncology.
    Fatima N; Zaman Mu; Gnanasegaran G; Zaman U; Shahid W; Zaman A; Tahseen R
    Asian Pac J Cancer Prev; 2015; 16(14):5599-605. PubMed ID: 26320423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multimodality equipment. A new vision in imaging diagnosis].
    Lapeña Gutiérrez L
    An R Acad Nac Med (Madr); 2010; 127(3):445-54; discussion 454-8. PubMed ID: 22263342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging.
    Wagenaar DJ; Kapusta M; Li J; Patt BE
    Technol Cancer Res Treat; 2006 Aug; 5(4):343-50. PubMed ID: 16866565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New trends and novel possibilities in functional medical imaging: imaging methods].
    Balkay L; Emri M; Krizsán KÁ; Opposits G; Varga J
    Magy Onkol; 2015 Mar; 59(1):4-9. PubMed ID: 25763907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/MR Imaging in Cardiovascular Imaging.
    Rischpler C; Woodard PK
    PET Clin; 2019 Apr; 14(2):233-244. PubMed ID: 30826021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The growing development of multimodality imaging in oncology.
    Papathanassiou D; Liehn JC
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):60-5. PubMed ID: 18765183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: current status, future aspects.
    Rakheja R; Chandarana H; Ponzo F; Seltzer AL; Beltran LS; Geppert C; Friedman KP
    PET Clin; 2014 Apr; 9(2):237-52. PubMed ID: 25030285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear Medicine and its promising applications in gynecological cancers.
    Lioupis M; Syrmos NCh
    Hell J Nucl Med; 2016; 19(1):63. PubMed ID: 26929944
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
    J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image-guided Treatment in the Hepatobiliary System: Role of Imaging in Treatment Planning and Posttreatment Evaluation.
    Bajpai S; Kambadakone A; Guimaraes AR; Arellano RS; Gervais DA; Sahani D
    Radiographics; 2015; 35(5):1393-418. PubMed ID: 26252365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative multimodality imaging in cancer research and therapy.
    Yankeelov TE; Abramson RG; Quarles CC
    Nat Rev Clin Oncol; 2014 Nov; 11(11):670-80. PubMed ID: 25113842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of SPECT-CT Hybrid Imaging Using Iterative Image Reconstruction for Low-Dose CT: A Phantom Study.
    Grosser OS; Kupitz D; Ruf J; Czuczwara D; Steffen IG; Furth C; Thormann M; Loewenthal D; Ricke J; Amthauer H
    PLoS One; 2015; 10(9):e0138658. PubMed ID: 26390216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/MRI for Lung Cancer Staging.
    Ohno Y; Koyama H; Lee HY; Yoshikawa T; Sugimura K
    J Thorac Imaging; 2016 Jul; 31(4):215-27. PubMed ID: 27075745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.